FY15 Rural Opioid Overdose Reversal Grant Program

HRSA-15-146

PRE-REVIEW CONFERENCE CALL

Purpose and goals

2

Purpose: reduce the incidences of morbidity and mortality related to opioid overdoses in rural communities through the purchase and placement of emergency devices used to rapidly reverse the effects of opioid overdoses and to provide training Goals:1. Purchase naloxone and opioid overdose reversal devices and

increase the availability in rural areas through strategic placement;

2. Train licensed healthcare professionals and others using the devices to recognize the signs of opioid overdose, administer naloxone, administer basic cardiopulmonary life support, report results, and provide appropriate transport to a hospital or clinic for continued care after administration;

Goals (cont):

3. Refer those with a drug dependency to appropriate substance abuse treatment centers where care coordination is provided by a team of providers; and

4. Demonstrate improved and measurable health outcomes, including but not limited to, reducing opioid overdose morbidity and mortality in rural areas.

3

Eligibility – Lead applicant must be:Rural and,Represent a community partnership

Community partnerships should consist of at least two organizations and be comprised of local emergency responders and other local non-profit and for profit entities involved in the prevention and treatment of opioid overdosesAll services must be performed in rural areas

The lead applicant (if awarded, will be the grantee of record)Must have financial and management systems in place

4

Required Attachments Attachment 1 – Staffing Plan and Job Description for Key

PersonnelAttachment 2 – Biographical SketchesAttachment 3 – Project Organizational ChartAttachment 4 – Opioid Overdose DataAttachment 5 – Partnership MOU/MOAAttachment 6 – Assessment PlanAttachment 7 – State statute or legislation regarding use of

naloxone for opioid overdosesAttachment 8 – Training Module

(refer to pages 10-11 of the FOA for full description) 5

Funding restrictions

As listed on page 11 of HRSA-15-146 (FOA):• For the purchase, construction, renovation, or improvement of

facilities or real property As listed on page 5 of HRSA-15-146 (FOA):• Intranasal forms of administration are not approved by the FDA

6

HRSA-15-039 Review criteriaProject Narrative Review Criteria Number of

points

• Introduction• Needs assessment

Criterion 1: Need See pages 12-13 of FOA

25

• Methodology• Work Plan• Resolution of

Challenges

Criterion 2: Response See page 13 of FOA

25

• Evaluation and technical support capacity

Criterion 3: Evaluative Measures See pages 13-14 of FOA

20

• Work Plan Criterion 4: ImpactSee page 14 of FOA

10

• Organizational information

Criterion 5: Resources/capabilitiesSee page 14 of FOA

15

• Budget• Budget justification

Criterion 6: Support requested See page 14 of FOA

5

7

Questions?

8